A phase II prospective, multi-institutional trial (CALGB 89903) of adjuvant active specific immunotherapy following curative resection of colorectal cancer(CRC) hepatic metastases

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Posner, MC; Niedzwiecki, D; Venook, AP; Hollis, DR; Schilsky, RL; Goldberg, RM; Mayer, RJ

Published Date

  • February 1, 2007

Published In

Volume / Issue

  • 14 / 2

Start / End Page

  • 3 - 3

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1068-9265

Conference Name

  • 60th Annual Cancer Symposium of the Society-of-Surgical-Oncology

Conference Location

  • Washington, DC

Conference Start Date

  • March 15, 2007

Conference End Date

  • March 18, 2007